ArticleExperimental and therapeutic medicine2021

Prognostic value of using glucosylceramide synthase and cytochrome P450 family 1 subfamily A1 expression levels for patients with triple-negative breast cancer following neoadjuvant chemotherapy.

Jiannan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.